Anoikis resistance is a hallmark of transformed epithelial cells. Here, we show that treatment of anoikis-resistant carcinoma cell lines with the endogenous lectin galectin-1 (Gal-1) promoted apoptosis via interaction with the unligated fibronectin receptor a 5 b 1 -integrin. Gal-1 efficiency correlated with expression of a 5 b 1 -integrin, and transfection of the a 5 -subunit into deficient cell lines conferred Gal-1 binding and anoikis stimulation. Furthermore, Gal-1 and the a 5 -and b 1 -integrin subunits co-precipitated in Gal-1-stimulated cells undergoing anoikis. Other members of the galectin family failed to be active. The functional interaction between Gal-1 and a 5 b 1 -integrin was glycan dependent with a2,6-sialylation representing a switch-off signal. Desialylation of cell surface glycans resulted in increased electrophoretic mobility of a 5 b 1 -integrin and facilitated Gal-1 binding and anoikis stimulation. On the level of signaling, Gal-1-stimulated anoikis was prevented by filipin, which impaired the internalization of a 5 b 1 -integrin via cholesterol-enriched microdomains, and by pretreatment with a caspase-8 inhibitor. We propose that Gal-1/ a 5 b 1 -integrin interaction participates in the control of epithelial integrity and integrin sialylation may enable carcinoma cells to evade this Gal-1-dependent control mechanism.
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Anoikis resistance is a hallmark of transformed epithelial cells. Here, we show that treatment of anoikis-resistant carcinoma cell lines with the endogenous lectin galectin-1 (Gal-1) promoted apoptosis via interaction with the unligated fibronectin receptor a 5 b 1 -integrin. Gal-1 efficiency correlated with expression of a 5 b 1 -integrin, and transfection of the a 5 -subunit into deficient cell lines conferred Gal-1 binding and anoikis stimulation. Furthermore, Gal-1 and the a 5 -and b 1 -integrin subunits co-precipitated in Gal-1-stimulated cells undergoing anoikis. Other members of the galectin family failed to be active. The functional interaction between Gal-1 and a 5 b 1 -integrin was glycan dependent with a2,6-sialylation representing a switch-off signal. Desialylation of cell surface glycans resulted in increased electrophoretic mobility of a 5 b 1 -integrin and facilitated Gal-1 binding and anoikis stimulation. On the level of signaling, Gal-1-stimulated anoikis was prevented by filipin, which impaired the internalization of a 5 b 1 -integrin via cholesterol-enriched microdomains, and by pretreatment with a caspase-8 inhibitor. We propose that Gal-1/ a 5 b 1 -integrin interaction participates in the control of epithelial integrity and integrin sialylation may enable carcinoma cells to evade this Gal-1-dependent control mechanism. Cell Death and Differentiation (2011) 18, 806-816; doi:10.1038/cdd.2010.148; published online 26 November 2010 Epithelial cells require attachment to an appropriate extracellular matrix (ECM) in order to survive. 1, 2 This anchorage is provided by integrins, heterodimeric transmembrane receptors that recognize and bind ECM ligands, and thereby induce reorganization of the actin-based adhesive structures of the cytoskeleton. In addition to this physical linkage, integrins act as sensors of the ECM environment. 3 They initiate intracellular signal transduction and/or create signaling platforms that modify signals generated by other classes of cell surface receptors.
When bound to appropriate ECM components, integrins cooperate with growth factors to activate mitogenic and antiapoptotic signaling pathways. 1 However, failure to engage with proper ECM components will not only deprive epithelial cells of these mitogenic and protective signals, but generate pro-apoptotic signals reminiscent of death-receptor activation. 4, 5 In consequence, epithelial cells that detach from the ECM or lack appropriately composed ECM undergo apoptosis in a process named 'anoikis' (Greek for homelessness) 2 or integrin-mediated cell death, 6 respectively. Integrins thereby provide a central safeguard mechanism to preclude survival of epithelial cells in inappropriate locations. Conversely, escape from anchorage dependence is a hallmark of carcinoma cells.
Nonetheless, cancer cells frequently retain or increase integrin expression, and overexpression of individual integrins correlated to invasive and metastatic phenotypes in clinical cancer specimens. 7 In experimental settings, ligated integrins promoted malignant cell behavior of carcinoma cells, but frequently fail to initiate cell death, when unligated. This failure may result from alterations either in downstream signaling cascades or integrin properties. In this context, changes in integrin glycosylation are receiving increasing attention. 8 In fact, altered glycosylation has long been associated with the malignant phenotype and inflammation. 9, 10 We previously identified galectin-1 (Gal-1) as a novel ligand that functionally interacts with the fibronectin receptor a 5 b 1 -integrin via binding to glycans. 11 Gal-1 belongs to the galectin family of adhesion/growth-regulatory endogenous lectins, which share specificity for b-galactosides and derivatives thereof, sequence similarity in the carbohydrate recognition domain and the jelly-roll folding. 12 Structurally, Gal-1 is a proto-type homodimeric protein with one binding site per subunit. 13 Cellular binding partners are suitable carbohydrate moieties of distinct glycoproteins and glycolipids. 12, 14 The ability for receptor-type-specific crosslinking renders it suited to modulate cell adhesion, migration and growth. 9, 12 Gal-1 interaction with the fibronectin receptor on adherent carcinoma cells attenuated cell cycle progression via induction of p21 and p27. 11 Upon cell detachment biological responses to Gal-1 might also be modified, prompting us to analyze Gal-1/fibronectin receptor interaction in carcinoma cells subjected to anoikis conditions. Our results identify Gal-1 as a potent activator of pro-apoptotic a 5 b 1 -integrin signaling, which imposed anchorage dependence by activating integrinassociated caspase-8.
Results
Gal-1 sensitizes HepG2 cells to anoikis. In initial experiments, we examined the effects of Gal-1 on growth and survival, when cells were deliberately kept from attaching to the substratum. Extending previous work with adherent cells, 11 hepatocellular HepG2 carcinoma cells were chosen as a representative Gal-1-responsive cell line with endogenous a 5 -integrin expression. These cells, when cultured on poly-HEMA, responded with a significant induction of apoptosis when treated with Gal-1, but not with vehicle or when kept under adherent conditions (Figure 1a) . Importantly, anoikis was also induced, when adherent cells first received Gal-1 treatment and were subsequently transferred to suspension cultures without further addition of Gal-1 (Figure 1b) . Thus, Gal-1 treatment sensitized HepG2 cells to anoikis, prompting us to identify the functional binding partner.
The fibronectin receptor is required for anoikis induction by Gal-1. As Gal-1 effects on growth of adherent cells required a 5 b 1 -integrin, 11 we assumed a similar interaction in Gal-1-stimulated anoikis of HepG2 cells and tested, whether anoikis could be prevented by coincubation with soluble fibronectin. Indeed, fibronectin prevented Gal-1-stimulated anoikis in a dose-dependent manner (Figure 1c) . Similarly, Gal-1-stimulated anoikis was prevented by a neutralizing a 5 b 1 -integrin-specific antibody (Figure 1c) . A functional interaction with a 5 b 1 -integrin was apparently required to elicit the pro-apoptotic effect, as was independently confirmed in a second cell line (Supplementary Figure 1) .
Encouraged by this evidence for a 5 b 1 -integrin involvement in Gal-1-mediated anoikis, we characterized a panel of 44 tumor cell lines of different histogenetic origin with respect to its expression and anoikis stimulation by Gal-1 (Figure 2) . The data collected provided the following insights: (i) Gal-1 significantly increased anoikis in 27 of the 44 cell lines ( Figure 2a) ; (ii) the six cell lines that were a 5 -subunit deficient were entirely insensitive to Gal-1 treatment; (iii) a 5 -integrin presence and susceptibility to Gal-1-mediated anoikis were significantly correlated (Pearson's r ¼ 0.6028, P ¼ 0.006; Figure 2b ); and (iv) Gal-1 responsiveness differed between cell lines derived from tumors of different histogenetic origin.
To provide further evidence for a functional role of a 5 b 1 -integrin in Gal-1-mediated anoikis, we used the Caco-2 cell system described previously. cell cycle regulation and stimulation of anoikis. Following transfection with cDNA for the a 5 -integrin subunit, Caco-2 cells had become responsive to Gal-1-induced cell cycle inhibition. 11 Using this cell model in suspension culture, enhanced Gal-1 surface reactivity (Figure 3a) and Gal-1-stimulated anoikis were seen in a 5 -transfected Caco-2 cells, but not in their mock-transfected controls (Figure 3b ). Maximal anoikis rates were reached in clones that displayed the highest level of a 5 -integrin expression (Figure 3b ). Furthermore, anoikis induction in clones with minute a 5 -integrin subunit expression did not reach statistical significance, suggesting that a certain density of a 5 b 1 -integrin was required Together, these experiments suggested that the fibronectin receptor conferred susceptibility to Gal-1-stimulated anoikis.
Anoikis stimulation by Gal-1 is galectin-type specific and inhibited by cognate sugar. We next explored the galectin-type specificity of anoikis stimulation using galectins-3 and -7 and the N-terminal domain of galectin-4, which represent another proto-type galectin very similar to Gal-1 (Gal-7), the chimera type (Gal-3) and the N-terminal part of a tandem-repeat-type galectin (Gal-4), respectively. We found that these other galectin family members were unable to stimulate anoikis (Supplementary Figure 2) . This observation was confirmed in two additional a 5 -integrinpositive, Gal-1-responsive cell lines, that is, DU145 and 97TM1 (Supplementary Figure 3) . Gal-1 interacts with cellular effectors via lectin-carbohydrate/protein interactions.
14 To document involvement of the carbohydrate recognition domain, the cognate sugar lactose, which inhibits binding of Gal-1 to glycans on the cell surface, was utilized. Addition of lactose, but not sucrose abrogated Gal-1-stimulated anoikis, whereas the haptenic inhibitor had no effect by itself (Supplementary Figure 2) .
Sialylation modulates Gal-1 binding and Gal-1-stimulated anoikis. Overall, the correlation between a 5 -integrin expression and Gal-1-stimulated anoikis supported the concept that glycans of the a 5 b 1 -integrin represent the functional interaction partner. However, several cell lines did not follow the assumed reactivity pattern. They may have a saturating level of Gal-1, prompting us to explore Gal-1 expression in our panel of cell lines by immunoblotting (Supplementary Figure 4) . However, Gal-1 (and also Gal-3) presence was variable, and high endogenous levels could occur in cell lines, which responded to addition of exogenous Gal-1, precluding a clear-cut correlation. These results turned attention to monitoring Gal-1 reactivity, testing PA1 and CRL1617 cells, which revealed less apoptosis induction than expected from their a 5 b 1 -integrin level, as well as U1752 cells, which were exceptionally responsive, although a 5 b 1 -integrin presentation was moderate (please see Figure 2 ). HepG2 cells were also included, as they responded to Gal-1 exposure as predicted from their a 5 -integrin content. Using biotinylated Gal-1 (Gal-1-bio) as probe, we barely detected probe binding to PA1 or CRL1617 cells when compared with HepG2 or U1752 cells ( Figure 4a) .
As terminal a2,6-sialylation of glycans blocks Gal-1 binding, 14 we hypothesized that low-level probe binding might result from sialylation of a 5 b 5 -integrin. Cells were thus cautiously treated with sialidase. The removal of a2-6-linked sialyl moieties from PA1 and CRL1617 cells were confirmed by reduced binding of Sambucus nigra agglutinin (SNA; a probe for a2,6-sialylated Gal/GalNAc residues). As a consequence of desialylation, the reactivities for Gal-1 and peanut agglutinin (PNA; a probe for sialic acid-free type-1 O-glycans) were increased in sialidase-treated PA1 and CRL1617 cells, but not in HepG2 cells (Figure 4a ). The rather small changes for HepG2 cells indicate a small degree of sialidase sensitivity under the given conditions. Overall, removal of masking sialylation increased Gal-1-binding sites. Parallel immunoblot analyses of a 5 -and b 1 -integrin subunits revealed a sialidase-dependent increase in electrophoretic mobility primarily for the b 1 -integrin subunit from PA1 and CRL1617 cells (Figure 4b ). In summary, Gal-1-stimulated anoikis in PA1 and CRL1617 cells was enhanced by sialidase treatment (Figure 4c) . Conversely, increased sialylation may reduce the responsiveness to Gal-1. As experimental test, we pretreated highly responsive U1752 cells for 48 h with 5 mM N-acetylmannosamine (ManNAc), a biosynthetic precursor of sialic acid, to enhance cell surface sialylation. Addition of ManNAc to U1752 cells cultures reduced the ability of Gal-1 to stimulate anoikis (Figure 5a ), as it did with the extent of lectin binding to the cell surface (Figure 5b ). Gal-1 reactivity and Gal-1-stimulated anoikis of HepG2 cells remained nearly unaffected, although we could detect sufficient amounts of free sialic acid in cell supernatants (not shown). Detailed monitoring of a2,3/6-sialylation on the cell surface with a panel of plant/human lectins after cell treatment with 5 and 20 mM ManNAc for 48 h fittingly revealed only slight increases (up to 12%), in full accord with the given data for Gal-1 (Figure 5b In summary, our data indicate that accessibility and/or functionality of a critical-binding partner of Gal-1 were modulated by sialylation.
Gal-1 directly associates and functionally interacts with a 5 b 1 -integrin. On the basis of (i) the requirement for a 5 b 1 -integrin expression for Gal-1-stimulated anoikis, (ii) increased Gal-1 binding in a 5 -integrin-transfected cells, and (iii) anoikis protection by fibronectin and the a 5 b 1 -integrinblocking antibody, Gal-1 likely associated with a 5 b 1 -integrin. The predicted complexes containing Gal-1 were found with a fibronectin-receptor-specific antibody in Gal-1-treated HepG2 cells (Figure 6a, left) . Addition of lactose, but not fibronectin abolished this co-immunoprecipitation. Using an antibody to Gal-1, the a 5 -and b 1 -integrin subunits were pulled down in the absence, but not in the presence of lactose (Figure 6a, middle) . Again, fibronectin did not prevent this complex formation, although it abrogated anoikis induction by Gal-1. Using Gal-1-coated magnetic beads a 5 b 1 -integrin was detected (Figure 6a, right) . Different from immunoprecipitations, fibronectin reduced the recovery of a 5 b 1 -integrin from Gal-1-coated beads, likely due to the altered experimental conditions with disparate Gal-1 presentation and a 30 min fibronectin pre-incubation before the application of Gal-1.
Taken together, Gal-1 appeared to physically interact with the fibronectin receptor outside the fibronectin-binding domain, fully in line with contact to integrin's N-glycans.
In the Caco-2 cell system, we co-precipitated the b 1 -subunit not only from Caco-2/a 5 -expressing cells, but also from parental a 5 -deficient cells with the Gal-1-specific antibody (Figure 6b) . Thus, Gal-1 can interact with the b-integrin subunit independent of a 5 -integrin expression. Having revealed evidence for direct interaction, we addressed Gal-1-initiated signaling next.
Gal-1 engagement of a 5 b 1 -integrin results in caspase-8 activation. As integrins may modulate survival via caspase-8 activation, we determined caspase-8 activity in Gal-1-treated HepG2 suspension cultures (Figure 7) . Treatment with Gal-1 resulted in rapid and progressive activation of caspase-8, when compared with untreated controls. To define the significance of this caspase-8 activation for Gal-1-stimulated anoikis, a specific caspase-8 inhibitor (Z-IETD-FMK) was added at various time points following Gal-1 stimulation. The inhibitor prevented Gal-1-dependent anoikis completely when added within 5 min of starting Gal-1 treatment (Figure 7b) . When added at later time points, Gal-1-mediated stimulation of anoikis could only be partially inhibited. Hence, Gal-1 stimulated anoikis required the Figure 8A ). Immunoblotting of membrane fractions corroborated the loss of a 5 b 1 -integrin ( Figure 8B ), whereas the overall integrin content of whole-cell lysates remained unchanged (Supplementary Figure 5) . Immunofluorescence microscopy similarly illustrated a redistribution of a 5 b 1 -integrin membrane reactivity into the cytosol of Gal-1-treated detached HepG2 cells ( Figure 8C ). Examination of other integrins ( Figure 8C and Supplementary Figure 6a) or stimulation with Gal-3 suggested that internalization of a 5 b 1 -integrin occurred specifically on addition of Gal-1. We then compared Gal-1-stimulated internalization of a 5 b 1 -integrin in cell lines that differed with respect to extent of Gal-1-stimulated anoikis and observed internalization exclusively in cell lines, which underwent anoikis (Supplementary Figure 7) . To directly test the functional relevance of the internalization process for Gal-1-stimulated anoikis, we used the macrolide filipin to perturb microdomain integrity ( Figure 8D ). Figure 8b) . Thus, microdomain integrity and Gal-1-induced internalization of its cognate integrin have a role for anoikis induction.
Discussion
The current study identifies human Gal-1 as a potent modulator of anchorage-independent survival in epithelial cancer cells. We provide evidence that (i) Gal-1 is capable of promoting anoikis in a series of cell lines of different histogenetic origin, (ii) Gal-1 binding depends on the presence of the fibronectin receptor and is modulated by sialylation of cell surface glycans, (iii) anoikis stimulation by Gal-1 requires a functional interaction with the fibronectin receptor and (iv) complex formation with this integrin promotes internalization of the integrin via filipin-sensitive cholesterol-enriched microdomains and activation of caspase-8, a process cascade triggering anoikis. Previously, we had found that Gal-1 interacted with the fibronectin receptor in adherent cells to induce cell cycle inhibition. 11 Here, we focused on Gal-1 interactions with the unligated integrin in suspension culture, which intriguingly promoted anoikis. When screening a panel of 44 carcinoma cells lines, we found the majority anoikis resistant despite expression of a 5 b 1 -integrin, suggesting the integrin had lost the capacity to impose anchorage dependence. Addition of Gal-1 restored anoikis susceptibility in most of these cells. To determine effects of filipin on anoikis, cells were cultured on Poly-HEMA and treated with Gal-1 (125 mg/ml) or filipin (4 mg/ml) or a combination thereof. For filipin conditions, cells had also been pretreated for 60 min before they were transferred to suspension culture. Anoikis rates were determined after 24 h. Results are expressed as fold of control and represent the mean ± S.E.M. of at least three independent experiments. ANOVA was performed using Prism software (Prism, San Diego, CA, USA). **Po0.01, ***Po0.001 
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Close association of the b 1 -integrin subunit and Gal-1 was evident from cross-linking and co-precipitation experiments, and Gal-1 has been implicated in b 1 -subunit surface presentation and trafficking. 18, 19 Also, Gal-1 was recovered from a 5 b 1 -integrin complexes in transfected K562 chronic myelogenous leukemia cells in a recent proteomic analysis. 20 The requirement for a 5 b 1 -integrin in Gal-1-stimulated anoikis furthermore fits the profile of this integrin as a relevant determinant of anchorage dependence. [21] [22] [23] Although expression of the fibronectin receptor was a prerequisite for Gal-1-stimulated anoikis, the capacity of the cell to produce Gal-1 turned out to be less predictive. Evidently, the signal intensity of western blots was not correlated to cell reactivity, possibly due to insufficient routing to the integrin and/or presence of other binding partners. A coordinated upregulation of Gal-1 production and its surface presentation is orchestrated via reexpression of the tumor suppressor p16
INK4a in a pancreatic cancer cell line. 24 Induction of Gal-1 was accompanied by reprogramming of glycosylation, leading to increased Gal-1 reactivity and potent induction of anoikis involving a 5 b 1 -integrin. 24 With respect to the cellular reactivity, accessibility of Gal-1-binding sites emerged as a crucial modifier. Specifically, enzymatic reduction of cell surface sialylation increased binding and anoikis response of cell lines that appeared resistant to Gal-1 despite abundant a 5 -integrin expression. Thus, consequences of integrin sialylation may extend beyond altered binding of protein ligands 8, 25, 26 due to an effective masking of lectin-reactive sites. Indeed, the presence of a2,6-linked sialic acid precluded cell binding of Gal-1, 27 even in N-acetyllactosamine repeats. 28 The current findings suggest a2,6-sialylation of a5b1-integrin constitutes a relevant (patho-)physiologic response modifier for Gal-1-stimulated cancer cell anoikis. Interestingly, this type of N-glycan branch-end structure is increased in various malignant cells. 10 In line with this concept, our immunoprecipitation analyses confirm a physical, lactose-inhibitable interaction of Gal-1 with the fibronectin receptor. Presence of both integrin subunits appears mandatory, as Gal-1 binding and pro-apoptotic signaling are negligible in Caco-2 or HT29 cell lines with abundant b 1 -integrin expression, unless they are transfected to produce the a 5 -integrin subunit. Although fibronectin counteracts Gal-1-stimulated anoikis, it did not consistently displace Gal-1 from a 5 b 1 -integrin complexes, suggesting physically separate interaction sites. Information on the precise localization of the glycans acting as docking sites will be required to answer topological aspects of this question.
Which signals trigger anoikis following the binding of Gal-1 to a 5 b 1 -integrin? Initiation and execution of the anoikis process rely on the activation of caspases via integrins, 1 though variability exists with respect to the sequence of caspase activation. Studies on a 5 b 1 -and a v b 3 -integrins describe an early and functionally relevant activation of procaspase-8. 5, 29 In fact, procaspase-8 was shown to promote migration and invasion of cancer cells, unless turned into an apoptotic signal by activation. 30 Here, we report a rapid procaspase-8 activation upon Gal-1 engagement of a 5 b 1 -integrin and impairment of Gal-1-stimulated anoikis with a selective caspase-8 inhibitor. Involvement of caspase-8 has also recently been demonstrated for anoikis induction in p16 INK4a -reconstituted cells, which required autocrine Gal-1 availability. 31 Different mechanisms are proposed, whereby integrins activate or suppress caspase-8 activity in a ligand-dependent manner, including proximity-induced activation of integrinassociated procaspase-8 due to integrin clustering, 6 prevention of autocatalytic cleavage by post-translational modifications, 30 ,32 redistribution of endogenous caspase inhibitors, 33 or increased availability of pro-apoptotic bcl-2 family members. 34 Here, we observed rapid internalization of a 5 b 1 -integrin via cholesterol-enriched microdomains, a process required for full anoikis induction. Thus, Gal-1 may provoke clustering and/or repartition of the unligated a 5 b 1 -integrin into endocytotic microdomains and thereby enable or amplify its capacity to activate caspase-8. Enhanced caspase-8 activation by death receptors, such as CD95, following recruitment to lipid rafts and endocytosis provides an example for modulation of apoptotic signaling by endocytotic trafficking. 35 Association of ganglioside GM1, which by itself is a potent Gal-1 counterreceptor, with this integrin, as noted in T effector cells, 36 may favor clustering in cholesterol-enriched microdomains, leading to enhanced Gal-1 reactivity 37 thereby supporting recruitment to microdomains and endocytosis.
In summary, we report Gal-1 as a counter receptor of N-glycans of the a 5 b 1 -integrin. Binding to the unligated integrin initiates apoptosis. Thus, Gal-1 is capable of implementing anchorage dependence in epithelial cancer cells. Cancer cells may circumvent this control mechanism by reducing access of Gal-1 to its target(s) on the cell surface via a2,6-sialylation. Thus, an acquired anoikis resistance of carcinoma cells may be encoded in glycans at the cell surface, besides being exerted by oncogenic alterations in downstream survival signaling pathways. Consequently, shifting the glycophenotype to a Gal-1-responsive profile offers an attractive alternate avenue for therapeutic intervention.
Materials and Methods
Cell culture. Human tumor cell lines were obtained from ATCC, the German Cancer Research Center (Heidelberg, Germany) (DanG cells), or the Japan Health Sciences Foundation (Health Science Research Resources Bank, Osaka, Japan) (QGP-1), and were grown exactly as recommended. BON (a generous gift from CM Townsend, Galveston, TX, USA) and LCC-18 neuroendocrine cancer cell lines were maintained in DMEM, supplemented with 10% (v/v) FCS, 100 units/ml penicillin and 100 mg/ml streptomycin.
Induction and detection of anoikis. For determination of anoikis, 2 Â 10 5 cells were cultured as suspension cultures on plates coated with poly (2-hydroxyethyl methacrylate) (poly-HEMA) (Sigma-Aldrich, Munich, Germany) for the indicated periods of time. Apoptotic cells were then quantitated from the pre-G 1 fraction in cell cycle analyses. 23 Production and purification of galectins. Human galectins -1, -3 and -7 and the N-terminal domain of rat tandem-repeat-type galectin-4 were purified with affinity chromatography as crucial step, rigorously checked for purity by one-and two-dimensional gel electrophoresis, mass spectrometry and gel filtration, and
